Gallbladder Stone Treatment in Delhi

 Gallbladder cancer originates from the gall bladder. The gallbladder is a small organ located just below the liver. It helps in fat metabolism in the body. The most common problem in the gallbladder is gallstones and almost everyone is aware of gall stones and get better Gallbladder Stone Treatment in Delhi, Gurugram, Gurgaon, Haryana.


 

Comments

Post a Comment

Popular posts from this blog

Duodenal Cancer Treatment in Delhi

Image
Duodenal Cancer, Risk Factors, Investigation,Sign and Symptoms Duodenum starts where stomach ends. It is first part of the small intestine and ends in the jejunum. The draining channel to drain bile from liver also ends in duodenum - called as common bile duct. Cancer arising from duodenum is duodenal cancer. It is a very rare kind of cancer. Less than one percent of all cancers arise from duodenum. This cancer can occur in anybody, however, it is most commonly seen above 60 years of age. Some risk factors increasing the likelihood for this cancer are: Age As already mentioned, these cancers are most commonly seen above 60 years i.e. increasing incidence with increasing age. Inflammatory bowel disease These are the disorders of the gut. They are of two main types, Ulcerative colitis, and Crohn’s disease. They cause chronic inflammation in the gut and have a waxing waning course. They predispose to cancers of both the small intestine and large intestine. Some kinds of genetic disorders
Read more

Immunotherapy Cancer in Delhi

Image
  Immunotherapy : A new arsenal against cancer Today, the world is witnessing remarkable advancements in the field of anti-cancer treatment. The latest on the list is “immunotherapy”. The concept of immunotherapy is based on boosting the body’s own immune cells to kill or control the growth of cancer cells. Unlike chemotherapy, where chemotherapy drugs kill cancer cells, immunotherapy drugs have no direct effect on the cancer cells. There are many types of anticancer immunotherapy drugs being tried in the trials. Cancer vaccines, oncolytic viral therapy, T cells, and immune checkpoint inhibitors are the ones that are most promising. Out of these, immune checkpoint inhibitors have gained maximum popularity. Currently, there is hardly any cancer where these drugs are not being tried in a clinical trial. Cancers cells have certain molecules expressed on their surface. These molecules inhibit immune cells and cause ca
Read more